Physician profile
Katrina M Hess
NPI 1639100159
$793.94
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $782 · 2020: $12.42.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esaote North America, INC. | $367.50 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $59.93 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $58.43 | 2019 | |
| Amgen INC. | $45.92 | 2019 | |
| Novo Nordisk INC | $40.03 | 2019 | |
| Allergan, INC. | $37.76 | 2019 | |
| Abbvie INC. | $31.20 | 2019 | |
| Pfizer INC. | $26.35 | 2019 | |
| Novartis Pharmaceuticals Corporation | $20.18 | 2019 | |
| Genentech USA, INC. | $18.93 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.21 | 2019 | |
| Glaxosmithkline, LLC. | $14.93 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.90 | 2019 | |
| Depuy Synthes Sales INC. | $14.71 | 2019 | |
| Bioventus LLC | $14.43 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $11.53 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.